Total Payments
$10,271
2024 Payments
$2,467
Companies
23
Transactions
154
Medicare Patients
684
Medicare Billing
$40,771
Payment Breakdown by Category
Consulting$5,620 (54.7%)
Food & Beverage$4,092 (39.8%)
Travel$335.25 (3.3%)
Education$223.20 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $5,620 | 6 | 54.7% |
| Food and Beverage | $4,092 | 144 | 39.8% |
| Travel and Lodging | $335.25 | 1 | 3.3% |
| Education | $223.20 | 3 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pharmacyclics LLC, An AbbVie Company | $2,670 | 7 | $0 (2023) |
| ABBVIE INC. | $2,088 | 9 | $0 (2024) |
| BeiGene USA, Inc. | $1,347 | 10 | $0 (2024) |
| CTI BioPharma Corp. | $806.63 | 7 | $0 (2023) |
| Astellas Pharma US Inc | $686.82 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $479.83 | 16 | $0 (2024) |
| Celgene Corporation | $286.68 | 16 | $0 (2024) |
| Lilly USA, LLC | $266.20 | 7 | $0 (2024) |
| SOBI, INC | $247.94 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $204.59 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,467 | 49 | BeiGene USA, Inc. ($1,157) |
| 2023 | $2,644 | 59 | CTI BioPharma Corp. ($806.63) |
| 2022 | $971.42 | 33 | Janssen Biotech, Inc. ($214.13) |
| 2021 | $4,189 | 13 | Pharmacyclics LLC, An AbbVie Company ($2,500) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $32.16 | General |
| Category: Oncology | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: Oncology | ||||||
| 11/15/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $43.94 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $33.72 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Lilly USA, LLC | JAYPIRCA (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Oncology | ||||||
| 11/07/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $26.77 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/24/2024 | Lilly USA, LLC | JAYPIRCA (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Oncology | ||||||
| 10/22/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| Category: Oncology | ||||||
| 10/17/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $31.39 | General |
| Category: Infectious Diseases | ||||||
| 10/03/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/02/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $102.60 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $31.32 | General |
| Category: Oncology | ||||||
| 09/25/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: Oncology | ||||||
| 09/17/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $148.45 | General |
| Category: Oncology | ||||||
| 09/17/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $100.92 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $29.61 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/21/2024 | Lilly USA, LLC | JAYPIRCA (Drug) | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: Oncology | ||||||
| 08/20/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 08/15/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: ONCOLOGY | ||||||
| 08/14/2024 | PFIZER INC. | BOSULIF (Drug), BESPONSA | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 08/08/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $33.66 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 168 | 225 | $39,152 | $10,132 |
| 2022 | 2 | 181 | 219 | $41,271 | $11,218 |
| 2021 | 4 | 195 | 237 | $42,581 | $12,421 |
| 2020 | 2 | 140 | 174 | $31,338 | $6,999 |
Total Patients
684
Total Services
855
Medicare Billing
$40,771
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 141 | 198 | $33,864 | $8,886 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 14 | $3,708 | $936.04 | 25.2% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2023 | 13 | 13 | $1,580 | $310.44 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 124 | 158 | $25,883 | $7,111 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 57 | 61 | $15,388 | $4,107 | 26.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 113 | 138 | $21,858 | $6,541 | 29.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 54 | 67 | $16,394 | $4,691 | 28.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 14 | 17 | $2,664 | $809.37 | 30.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 14 | 15 | $1,665 | $379.35 | 22.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 92 | 114 | $17,196 | $3,866 | 22.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 48 | 60 | $14,142 | $3,133 | 22.2% |
About Jacqueline Broadway, MSN, FNP
Jacqueline Broadway, MSN, FNP is a Family healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760569891.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jacqueline Broadway, MSN, FNP has received a total of $10,271 in payments from pharmaceutical and medical device companies, with $2,467 received in 2024. These payments were reported across 154 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($5,620).
As a Medicare-enrolled provider, Broadway has provided services to 684 Medicare beneficiaries, totaling 855 services with total Medicare billing of $40,771. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Houston, TX
- Active Since 11/01/2006
- Last Updated 10/27/2010
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1760569891
Products in Payments
- IMBRUVICA (Drug) $3,164
- VENCLEXTA (Drug) $2,059
- BRUKINSA (Drug) $1,347
- Vonjo (Drug) $806.63
- Xospata (Drug) $393.15
- REBLOZYL (Biological) $253.28
- VONJO (Drug) $229.07
- CALQUENCE (Drug) $204.59
- clonoSEQ (Device) $192.73
- BESREMI (Drug) $163.13
- JAYPIRCA (Drug) $157.19
- JAKAFI (Drug) $150.67
- BOSULIF (Drug) $112.00
- Cresemba (Drug) $111.68
- Blincyto (Biological) $81.75
- GAZYVA (Biological) $67.25
- LONSURF (Drug) $62.68
- Rezlidhia (Drug) $57.51
- Vanflyta (Drug) $54.30
- SPRYCEL (Drug) $33.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Houston
Mrs. Sarah Aguilar, N.p, N.P
Family — Payments: $167,309
Family $167,309
Margaret White, Fnp-Bc, FNP-BC
Family — Payments: $71,272
Family $71,272
Mrs. Katrina King, Arnp, ARNP
Family — Payments: $43,591
Family $43,591
Shaila Khowja, Fnp-C, FNP-C
Family — Payments: $25,332
Family $25,332
Kendrick Clack, Fnp-C, FNP-C
Family — Payments: $22,281
Family $22,281
Tammy Davis
Family — Payments: $18,660
Family $18,660